axel merseburger, esmo 2019 - advances in metastatic hormone-sensitive prostate cancer
Published 5 years ago • 645 plays • Length 4:40Download video MP4
Download video MP3
Similar videos
-
2:02
axel merseburger - ecc 2015, vienna - part 1: relapse after adt in patients with prostate cancer
-
5:33
expert highlights: genitourinary cancers at esmo 2019 | axel merseburger
-
4:39
clinical insights into prostate cancer trial data | axel merseburger
-
3:41
julie graff, esmo 2019 - keynote-641 study in prostate cancer
-
1:29
axel merseburger - ecc 2015, vienna - part 3: new therapeutic approaches in prostate cancer
-
2:25
warning signs of lymphoma
-
1:13:14
advanced prostate cancer
-
3:02
prostate surgery
-
18:01
clinical updates for metastatic hormone sensitive prostate cancer at asco 2019
-
26:35
esmo 2021: updates in hormone-sensitive prostate cancer
-
5:45
axel s merseburger: mitomycin pyelocalyceal: non-surgical treatment for patients with low-grade utuc
-
3:04
researcher comment: apalutamide addition improves metastatic cspc survival | axel merseburger
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
6:05
axel merseburger, asco20: clinical updates in urothelial carcinoma and renal cell carcinoma
-
6:40
genitourinary cancers: clinical insights into trial data | axel merseburger
-
15:19
latest developments in metastatic prostate cancer from esmo 2019
-
4:35
support for continuing enzalutamide after mcrpc progression | axel merseburger
-
1:43
dr. oh on the role of docetaxel in metastatic hormone-sensitive prostate cancer
-
1:05
axel merseburger - ecc 2015, vienna - part 2: management of adverse effects in adt
-
11:31
managing patients with gu cancers in the time of covid-19 | cora sternberg and axel merseburger
-
7:04
eau15: merseburger and meitland about differing perspectives on anti-androgen therapy
-
4:36
expert report on latest data in the management of metastatic prostate cancer from asco 2022